References
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi.org/10.1002/ijc.25516
- Mitsudomi T. Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations. Transl Lung Cancer Res 2014; 3:205-11; PMID:25806302; http://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.04
- Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83:584-94; PMID:18452692; http://dx.doi.org/10.1016/S0025-6196(11)60735-0
- Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010; 42:200-2; PMID:20173748; http://dx.doi.org/10.1038/ng.535
- Young RP, Hopkins RJ, Hay BA, Whittington CF, Epton MJ, Gamble GD. FAM13A locus in COPD is independently associated with lung cancer - evidence of a molecular genetic link between COPD and lung cancer. Appl Clin Genet 2011; 4:1-10; PMID:23776362; http://dx.doi.org/10.2147/TACG.S15758
- Kenfield SA, Wei EK, Stampfer MJ, Rosner BA, Colditz GA. Comparison of aspects of smoking among the four histological types of lung cancer. Tob Control 2008; 17:198-204; PMID:18390646; http://dx.doi.org/10.1136/tc.2007.022582
- Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75:191-202; PMID:8000996; http://dx.doi.org/10.1002/1097-0142(19950101)75:1+%3c191::AID-CNCR2820751307%3e3.0.CO;2-Y
- Corvol H, Hodges CA, Drumm ML, Guillot L. Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases? J Med Genet 2014; 51:646-9; PMID:25163686; http://dx.doi.org/10.1136/jmedgenet-2014-102525
- Malliri A, Collard JG. Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol 2003; 15:583-9; PMID:14519393; http://dx.doi.org/10.1016/S0955-0674(03)00098-X
- Jin Z, Chung JW, Mei W, Strack S, He C, Lau GW, Yang J. Regulation of nuclear-cytoplasmic shuttling and function of Family with sequence similarity 13, member A (Fam13a), by B56-containing PP2As and Akt. Mol Biol Cell 2015; 26:1160-73; PMID:25609086; http://dx.doi.org/10.1091/mbc.E14-08-1276
- Chen W, Konkel JE. Development of thymic Foxp3(+) regulatory T cells: TGF-beta matters. Eur J Immunol 2015; 45:958-65; PMID:25684698; http://dx.doi.org/10.1002/eji.201444999
- Gaber T, Strehl C, Sawitzki B, Hoff P, Buttgereit F. Cellular energy metabolism in T-lymphocytes. Int Rev Immunol 2015; 34:34-49; PMID:25259409; http://dx.doi.org/10.3109/08830185.2014.956358
- Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011; 146:772-84; PMID:21871655; http://dx.doi.org/10.1016/j.cell.2011.07.033
- Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition. Am J Clin Oncol 2016; 39:98-106; PMID:26558876; http://dx.doi.org/10.1097/COC.0000000000000239
- Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV, Yang E, Johnson RS, Goldrath AW. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol 2013; 14:1173-82; PMID:24076634; http://dx.doi.org/10.1038/ni.2714
- Buck MD, O'Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med 2015; 212:1345-60; PMID:26261266; http://dx.doi.org/10.1084/jem.20151159
- Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ. TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst 2014; 106:djt369; PMID:24511106; http://dx.doi.org/10.1093/jnci/djt369
- Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182:311-22; PMID:10653597; http://dx.doi.org/10.1002/(SICI)1097-4652(200003)182:3%3c311::AID-JCP1%3e3.0.CO;2-9
- Massague J. TGFbeta in cancer. Cell 2008; 134:215-30; PMID:18662538; http://dx.doi.org/10.1016/j.cell.2008.07.001
- Wolf D, Sopper S, Pircher A, Gastl G, Wolf AM. Treg(s) in cancer: friends or foe? J Cell Physiol 2015; 230:2598-605; PMID:25913194; http://dx.doi.org/10.1002/jcp.25016
- Andreev K, Trufa ID, Siegemund R, Rieker R, Hartmann A, Schmidt J, Sirbu H, Finotto S. Impaired T-bet-pSTAT1alpha and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma. Br J Cancer 2015; 113:902-13; PMID:26348446; http://dx.doi.org/10.1038/bjc.2015.255
- Garon EB. Current perspectives in immunotherapy for non-small cell lung cancer. Semin Oncol 2015; 42(Suppl 2):S11-8; PMID:26477470; http://dx.doi.org/10.1053/j.seminoncol.2015.09.019
- Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 2003; 112:645-57; PMID:12628185; http://dx.doi.org/10.1016/S0092-8674(03)00154-5
- Zhang L, Yi H, Xia XP, Zhao Y. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance. Autoimmunity 2006; 39:269-76; PMID:16891215; http://dx.doi.org/10.1080/08916930600753903
- Henson ES, Gibson SB. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signalling 2006; 18:2089-97; 16815674; http://dx.doi.org/10.1016/j.cellsig.2006.05.015
- Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12:27-36; PMID:11160820; http://dx.doi.org/10.1091/mbc.12.1.27
- Krakhmal N, Zavyalova M, Denisov E, Vtorushin S, Perelmuter V. Cancer invasion: patterns and mechanisms. Acta Naturae 2015; 7:17-28; PMID:26085941
- Clark AG, Vignjevic DM. Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol 2015; 36:13-22; PMID:26183445; http://dx.doi.org/10.1016/j.ceb.2015.06.004
- Plotnik JP, Budka JA, Ferris MW, Hollenhorst PC. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells. Nucleic Acids Res 2014; 42:11928-40; PMID:25294825; http://dx.doi.org/10.1093/nar/gku929
- Hess Michelini R, Doedens AL, Goldrath AW, Hedrick SM. Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med 2013; 210:1189-200; PMID:23712431; http://dx.doi.org/10.1084/jem.20130392
- Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013; 29:15-21; PMID:23104886; http://dx.doi.org/10.1093/bioinformatics/bts635
- Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014; 30:923-30; PMID:24227677; http://dx.doi.org/10.1093/bioinformatics/btt656
- Team RDC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 2011.
- Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15:550; PMID:25516281; http://dx.doi.org/10.1186/s13059-014-0550-8
- Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, Liaw A et al. gplots: various R programming tools for plotting data. R package version 2.17.0 2015.